{"podcast":{"title":"Stock Spotlight","slug":"stock-spotlight-7027390","podcast_index_feed_id":7027390,"rss_url":"https://anchor.fm/s/fa8f9bac/podcast/rss","website_url":"https://linktr.ee/stockspotlight","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/41937155/41937155-1775053977515-c9510ae3d084f.jpg","author":"Michael","episode_count":34,"summary":"Stock Spotlight is a podcast dedicated to highlighting intriguing investment opportunities. In each episode, host Michael shines a light on promising stocks that have earned a 'watch' or 'pass' rating on his 33-question research checklist. Listeners can expect a thorough exploration of selected companies, covering their business models, financial performance and market positioning. As the show evolves, Michael will also delve into broader investing topics.","last_synced_at":"2026-07-17T00:21:02.104207+00:00","page_url":"https://stenobird.com/podcast/stock-spotlight-7027390"},"episode":{"title":"Medpace Holdings, Inc. (MEDP): Undervalued CRO or Funding-Dependent Risk?","slug":"medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk","published_at":"2025-04-02T13:30:00+00:00","page_url":"https://stenobird.com/podcast/stock-spotlight-7027390/medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk","show_page_url":"https://stenobird.com/podcast/stock-spotlight-7027390","url":"https://podcasters.spotify.com/pod/show/mf369/episodes/Medpace-Holdings--Inc--MEDP-Undervalued-CRO-or-Funding-Dependent-Risk-e30g7ii","audio_url":"https://anchor.fm/s/fa8f9bac/podcast/play/100195346/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-2-21%2F721c223a-12e9-88bd-de63-77eb3b792adc.mp3","summary":"On this episode of Stock Spotlight, Michael analyzes Medpace Holdings (MEDP), a unique player in the contract research organization (CRO) space. Unlike industry giants focused on big pharma, Medpace specializes in small to mid-sized firms - a double-edged sword that grants pricing power, but also exposes it to biotech funding volatility. With a potential return to double-digit growth in 2026, Medpace meets the criteria for a Quality Growth company, but its narrow moat, lack of true market leadership and poor Glassdoor ratings raise red flags. From a valuation standpoint, Medpace appears modestly undervalued, yet technical indicators signal caution. Is Medpace a hidden gem in the healthcare sector or a high-risk bet reliant on biopharma funding stability? Tune in as Michael unpacks his strategy for this niche CRO. ---------------------------------------------------------------- 00:00 Intro 00:38 Investment Checklist & Database 02:31 Business & Industry Overview 13:23 Business Model & Quality Growth Attributes 22:19 Financial Statement Overview 30:05 Management & Ownership Structure 34:48 Growth Areas & Risk Factors 37:46 KPIs to Track 38:43 Valuation & Technical Analysis 43:46 Episode Takeaways 44:36 Outro ---------------------------------------------------------------- Intro Music: Andrey Rossi – Seize the Day Outro Music: Ra – Prospect *Music provided by Uppbeat Premium Follow me on X: https://twitter.com/invest091 Subscribe to my YouTube channel: https://www.youtube.com/@stockspotlightpodcast ---------------------------------------------------------------- Disclosure: The host of Stock Spotlight is not a licensed financial advisor. The information and opinions shared during the show are for entertainment purposes only.","meta_description":"On this episode of Stock Spotlight, Michael analyzes Medpace Holdings (MEDP), a unique player in the contract research organization (CRO) space. Unlike in…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2711,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/stock-spotlight-7027390/episodes/medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/stock-spotlight-7027390/medpace-holdings-inc-medp-undervalued-cro-or-funding-dependent-risk.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}